Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

EU wins arbitration in pharma trade dispute with Turkey

Economy Jul 25, 2022 12:26PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: European Union (L) and Turkish flags fly outside a hotel in Istanbul, Turkey May 4, 2016. REUTERS/Murad Sezer/File Photo

GENEVA (Reuters) -The European Union received a largely favourable ruling in its trade dispute with Turkey on Monday in the first appeal settled by arbitration to circumvent problems at the World Trade Organization (WTO).

Brussels brought the case against Ankara to the WTO in 2019, challenging Turkey's "localisation requirement". The EU said this forced foreign pharmaceutical producers to move their production to Turkey in order for Turkish consumers to qualify for reimbursement when buying their products in pharmacies.

A WTO panel previously rejected Ankara's arguments and recommended it bring its measures in line with global trade rules. This prompted an appeal by Turkey in April, although the appeal had to go down an untested route.

The WTO's Appellate Body, which would normally hear such appeals, has been unable to issue a ruling since 2020 after former U.S. President Donald Trump's blocked new appointments, a policy the current U.S. administration has not reversed.

The Appellate Body's paralysis means that disputes enter a legal void. To resolve that, the European Union and Turkey agreed to send the case to non-WTO arbitrators and to abide by their findings.

This is the first time an appeal in a WTO dispute has gone down this route.

Arbitrators backed some of Turkey's arguments, but supported the earlier WTO panel finding that the localisation requirement breached global trading rules and advised Turkey to adjust its measure accordingly.

EU wins arbitration in pharma trade dispute with Turkey
 

Related Articles

Scale of UK's market slide spells out home truths
Scale of UK's market slide spells out home truths By Reuters - Sep 29, 2022

By Andy Bruce and Vincent Flasseur LONDON (Reuters) - This week's plunge in UK financial assets accelerated a longer historic decline signalling a loss of confidence among...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email